FILTERTEK INC. – Trademark Portfolio
Entity Type: 03
FILTERTEK INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 10 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 9 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEDIPURE. The owner is based in HEBRON, IL.
P.O. BOX 310
11411 PRICE ROAD
HEBRON, IL 60034
Showing of trademarks Trademarks
Trademark Classifications
FILTERTEK INC.'s trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does FILTERTEK INC. have?
FILTERTEK INC. has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned, 9 cancelled.
What trademark classes does FILTERTEK INC. file in?
FILTERTEK INC. files trademarks across 9 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 12 (Vehicles), Class 7 (Machinery), Class 11 (Environmental Control), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are FILTERTEK INC.'s most well-known trademarks?
FILTERTEK INC.'s registered trademark portfolio includes well-known marks such as MEDIPURE. These are among 1 currently registered trademark in the portfolio.
What is FILTERTEK INC.'s trademark registration success rate?
FILTERTEK INC. has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.